Rennova Health Inc (CLRX) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rennova Health Inc   (CLRX)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Rennova Health Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Rennova Health Inc's ROI in the fourth quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Rennova Health Inc 's return on investment (ROI) in its fourth quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -22 -25 -25 -25 -26
Return On Investment (TTM) - - - - -
CLRX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - 50.34 % - - -
Net Income (TTM) in Millions -8 2 2 0 -3

CLRX Company Profile >> Back to CLRX Roi Comparisons >> See Annual CLRX Return On Investment



Return On Investment CLRX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Rennova Health Inc's IV. Quarter Investments $ -22 Millions CLRX's Balance sheet
Rennova Health Inc's IV. Quarter Income $ -9 Millions Quarterly CLRX's Income Statement
CLRX's Income by Division See CLRX's Income by Division


CLRX Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions -22 -26 -27 -47 -71
Y / Y Investment Growth - - - - -
Net Income in Millions -8 -3 6 -18 -172
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CLRX's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CLRX's Competitors
Subscribers only: Roi for Rennova Health Inc's Suppliers
Subscribers only: Return On Investment for CLRX's Customers

Other Ratios
CLRX's Roa CLRX's Inventory Turnover Ratio CLRX's Growth Rates CLRX's Dividend Statistics
CLRX's Profitability Ratios CLRX's Asset Turnover Ratio CLRX's Dividend Growth
CLRX's Roe CLRX's Valuation Ratios CLRX's Financial Strength Ratios CLRX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI
Profound Medical Corp   76.09 %
Cv Sciences Inc   76.03 %
Galmed Pharmaceuticals Ltd   74.21 %
Scynexis Inc   65.85 %
Dariohealth Corp   62.29 %
Cardiff Lexington Corporation  55.55 %
Biomx Inc  51.59 %
Procaps Group S a   50.81 %
Voyager Therapeutics Inc   47.85 %
Enzo Biochem Inc  47.58 %
Mimedx Group Inc   45.14 %
Siga Technologies Inc  43.86 %
Scinai Immunotherapeutics Ltd  43.64 %
Idexx Laboratories Inc  40.73 %
Star Equity Holdings Inc   40.08 %
Elite Pharmaceuticals Inc   39.87 %
Medpace Holdings Inc   37.64 %
Mettler toledo International Inc   34.44 %
Nrc Health  33.18 %
Semler Scientific inc   30.60 %
Alpha Tau Medical Ltd  28.76 %
Escalon Medical Corp   27.28 %
Johnson and Johnson  26.63 %
Lantheus Holdings Inc   25.80 %
Inmode Ltd   24.77 %
Earth Science Tech Inc   24.00 %
Iradimed Corporation  23.38 %
Tenax Therapeutics Inc   22.90 %
Spero Therapeutics Inc   22.70 %
Alkermes Plc   21.82 %

Date modified: 2026-09-08T15:11:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.